Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 33
  • 0 comments

FDA approve OCTREOTIDE ACETATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 39
  • 0 comments

FDA approve OCTREOTIDE ACETATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 27, 2024, 21:50 UTC
  • 43
  • 0 comments

FDA approve USTEKINUMAB-AAUZ

Comment Full text

GE HEALTHCARE

  • FDA Approval
  • Sept. 27, 2024, 18:33 UTC
  • 36
  • 0 comments

FDA approve FLURPIRIDAZ F 18

Comment Full text

ACQ PHARMA

  • FDA Approval
  • Sept. 27, 2024, 18:33 UTC
  • 39
  • 0 comments

FDA approve MISOPROSTOL

Comment Full text

BRISTOL-MYERS SQUIBB

  • FDA Approval
  • Sept. 27, 2024, 14:12 UTC
  • 38
  • 0 comments

FDA approve XANOMELINE;TROSPIUM CHLORIDE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 42
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

ALEMBIC

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 33
  • 0 comments

FDA approve PALIPERIDONE

Comment Full text

SYNTHON PHARMS INC

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 41
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text

AMNEAL

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 45
  • 0 comments

FDA approve METHYLPREDNISOLONE

Comment Full text
  • Previous
  • 295
  • 296
  • 297
  • 298
  • 299
  • Next

Search

News categories

  • Technical Exchange News(10602)
  • Event(2021)
  • SEC News(184969)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122496)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin